PRODUCT FILTER
Categories
Type
Type

Partamol 150 Supp.
OTC

Partamol 150 Supp. is a rectal suppository which is released at body temperature (37°C), so it should be placed in the refrigerator (4 – 10°C) 5 – 10 minutes before use.

Pack size Box of 10 suppositories, 20 suppositories
Shelf-life 24 months
Composition Paracetamol
Dosage forms and strengths Rectal suppository: 150 mg
Product code :

PRESCRIBING INFORMATION

Indications

  • Symptomatic treatment of mild to moderate pain and/or feverish states for infants weighing 8 to 12 kg (approximately 6 to 24 months).

Dosage

  • Infants weighing 8 to 12 kg (approximately 6 to 24 months): 01 Partamol 150 Supp. suppository/every 6 hours.
  • The suppository administration should not exceed 4 doses per day, and the duration of rectal treatment should be as short as possible.
  • In case of diarrhea, the suppository form is not recommended.
  • Renal failure
    In case of renal insufficiency and except medical advice, it is recommended to reduce the dose and increase the minimum interval between 2 intakes. The total dose of paracetamol should not exceed 60 mg/kg/day.
  • Hepatic insufficiency
    The dose of paracetamol should not exceed 60 mg/kg/day.
  • Special clinical situations
    The lowest possible effective daily dose should be considered, without exceeding 60 mg/kg/day under the following conditions: Mild to moderate hepatocellular insufficiency, Gilbert’s syndrome (familial non-haemolytic jaundice), chronic alcoholism, chronic malnutrition, dehydration.

Usage

  • Partamol 150 Supp. is for rectal administration only.
  • In children, they must be regularly spaced, including at night, preferably 6 hours, and at least 4 hours.
  • Partamol 150 Supp. is a rectal suppository which is released at body temperature (37°C), so it should be placed in the refrigerator (4 – 10°C) 5 – 10 minutes before use.
  • Hypersensitivity to the active substance or to any of the excipients.
  • Severe hepatocellular insufficiency or decompensated active liver disease.
  • Recent history of proctitis, anitis or rectal bleeding.
  • Very exceptional cases of thrombocytopenia, leukopenia and neutropenia have been reported.
  • Cases of diarrhoea, abdominal pain, increased liver enzymes, increased or decreased INR have been reported.
  • Rectal and anal irritation.
  • With suppositories, there is a risk of local irritation.
  • The physicians need to warn the patients of the signs of serious skin reactions known as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) or Lyell’s syndrome, acute generalized exanthematous pustulosis (AGEP).
  • When detecting first signs of skin rash or any other hypersensitivity reactions, patients should stop using the drug. Who have already had serious skin reactions caused by paracetamol shouldn’t use the medicine again and should inform the medical staff to know about this issue.
  • If acute viral hepatitis is discovered, treatment should be stopped.
  • In case of diarrhea, the suppository form is not suitable.
  • If clinically needed, paracetamol can be used during pregnancy however it should be used at the lowest effective dose for the shortest possible time and at the lowest possible frequency.
  • In therapeutic doses, the administration of this drug is possible during lactation.
  • Paracetamol has no or negligible influence on the ability to drive and use machines.